title: [Diabetes treatment in patients with chronic kidney disease].
authors.affiliation: Medizinische Klinik I, Universitätsklinikum Schleswig-Holstein, Campus Lübeck. suefkes@uni-luebeck.de
authors.forename: S
authors.initials: S
authors.lastname: Süfke
authors.forename: J
authors.initials: J
authors.lastname: Steinhoff
authors.forename: M
authors.initials: M
authors.lastname: Schütt
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000188:drug therapy*; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005905:Glyburide / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000175:diagnosis*; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000188:drug therapy*; D007677:Kidney Function Tests; D008297:Male; D008687:Metformin / Q000009:adverse effects* / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D011719:Pyrazines; D014230:Triazoles; D008687:Metformin; D005905:Glyburide; D000068900:Sitagliptin Phosphate